Omnibus Autism Proceeding

m Bookmark and Share
The American Nurses Association (ANA) Dept. of Nursing Practice and Policy shares the following information from the U.S. Court of Federal Claims:

On March 12, 2010, the U.S. Court of Federal Claims ruled in three separate cases concluding that thimerosol-containing vaccines do not cause autism. Under the Omnibus Autism Proceeding, test cases were reviewed that sought compensation under the National Vaccine Injury Prevention Program stating thimerosol was a substantial contributing factor to the causation of autism. The federal court ruled that the evidence supporting an alleged causal link between autism and thimerosol-containing vaccines is unpersuasive, and that the families of children diagnosed with autism are not entitled to compensation.

The Omnibus Autism Proceeding was created by the National Vaccine Injury Compensation Program to handle claims against vaccines. The U.S. Court of Federal Claims divided the claims into three theories and designated “test cases” for each theory. On February 12, 2009, the federal court ruled on the First Theory and concluded that MMR vaccines, in combination with thimerosal-containing vaccines do not cause or contribute to autism. This March 12th ruling, settles the claim for the Second Theory that thimerosal-containing vaccines can alone cause autism. The hearing for the Third Theory, that MMR vaccine alone can cause autism, was voluntarily withdrawn by the petitioners.

To read the U.S. Court of Federal Claims decision: